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In this study, we investigated the reorganized basolateral amygdala (BLA)-subiculum
pathway in a status epilepticus (SE) mouse model with epileptic episodes induced by
pilocarpine. We have previously observed a dramatic loss of neurons in the CA1–3
fields of the hippocampus in epileptic mice. Herein, we observed a 43–57% reduction
in the number of neurons in the BLA of epileptic mice. However, injection of an
anterograde tracer, Phaseolus vulgaris leucoagglutinin (PHA-L) into the BLA indicated
25.63% increase in the number of PHA-L-immunopositive terminal-like structures in the
ventral subiculum (v-Sub) of epileptic mice as compared to control mice. These data
suggest that the projections from the basal nucleus at BLA to the vSub in epileptic mice
are resistant to epilepsy-induced damage. Consequently, these epileptic mice exhibit
partially impairment but not total loss of context-dependent fear memory. Epileptic
mice also show increased c-Fos expression in the BLA and vSub when subjected to
contextual memory test, suggesting the participation of these two brain areas in foot
shock-dependent fear conditioning. These results indicate the presence of functional
neural connections between the BLA-vSub regions that participate in learning and
memory in epileptic mice.
Keywords: reorganization, basolateral amygdala, subiculum, epilepsy, mouse, pilocarpine, contextual fear
memory test, c-Fos
INTRODUCTION
The amygdala, hippocampus, parahippocampal regions and their interconnected neural circuits
have been implicated in the fear memory consolidation processes (Kim and Fanselow, 1992;
Kjelstrup et al., 2002; Frankland et al., 2006; Botterill et al., 2014). Lesions to these brain
regions have also been found in patients with temporal lobe epilepsy (TLE; Quesney, 1986;
Hudson et al., 1993; Wolf et al., 1997; Bernasconi et al., 2003; Gyimesi et al., 2010; Meletti
et al., 2014) and in animal models of TLE (Schwob et al., 1980; Ben-Ari, 1985; Pitkänen et al.,
1998; Brandt et al., 2006; Toyoda et al., 2013). Moreover, patients with TLE and animal
models of TLE with such lesions exhibit interictal emotional disturbances and impaired
emotional learning that are known to be amygdala- and/or hippocampus-dependent (Hort
et al., 1999; Vazquez and Devinsky, 2003; Kemppainen et al., 2006; Cardoso et al., 2009).
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The pilocarpine-induced mouse model of TLE is commonly
used for modeling TLE in humans. These epileptic mice share
similar neuropathological mechanisms and seizure states with
human TLE; animals experiencing status epilepticus (SE) for
several hours showed histopathological alterations throughout
the limbic system (Coulter, 1999; Curia et al., 2008; Tang
and Loke, 2010; Reddy and Kuruba, 2013). The affected areas
involve not only the hippocampus but also the amygdala,
the entorhinal cortex (Du et al., 1995; Biagini et al., 2005;
Wozny et al., 2005; Ma et al., 2008), the piriform cortex, the
thalamus (Mathieson, 1975; Mello and Covolan, 1996), and
specifically the midline thalamic nuclei (including the medial
dorsal nucleus; Ben-Ari et al., 1980; Lothman and Collins, 1981;
Cavalheiro et al., 1991). Although these affected areas are directly
connected to the hippocampus and are similar to those found
in human TLE, it is still unclear if there are any lesions in
other regions not observed in human TLE. Therefore, it is
possible that the extensive brain lesions in the pilocarpine-
induced epilepsy mouse model are not necessarily related with
the TLE condition per se. Nonetheless, the epilepsy mouse model
induced by pilocarpine is still a valuable tool for understanding
the pathological mechanisms of epilepsy in general as well
as to determine the suitability of this mouse model as an
experimental model of TLE (Curia et al., 2008). In addition to the
standard epilepsy or TLE mouse model used here, there are also
modified models considering the appropriate SE duration and
the methods of SE induction in animals to reproduce the most
extensive characteristics of human TLE (Depaulis and Hamelin,
2015).
Lesions in the basolateral amygdala (BLA) region abolished
conditional freezing in response to contextual cues associated
with foot shocks, suggesting that BLA is important in mediating
conditioned fear responses (Maren et al., 1996; Fanselow
and LeDoux, 1999; Vazdarjanova and McGaugh, 1999). There
are also studies that have shown that damage to the BLA
alone did not result in deficits in contextual or auditory fear
memory (Goosens and Maren, 2001; Rabinak et al., 2009).
Thus, the involvement of BLA in contextual fear memory
is still unclear. We previously reported substantial neuronal
damage in the CA1–3 fields of the hippocampus (Ma et al.,
2006; Tang et al., 2006) in SE animals. There are also studies
from other groups using the same standard or modified
mouse epilepsy model that showed impaired extinction of
fear and maintained amygdala-hippocampal theta synchrony
(Lesting et al., 2011); c-Fos, JunD and HSP27 immunoreactivity
in different parts of the brain following SE (Dubé et al.,
1998); impairs spatial memory (Detour et al., 2005); and
depressive impairments (Pineda et al., 2010). However, the
organization of the neural circuitry of the BLA and subiculum
in contextual fear memory in these SE animals is still
unknown.
Herein, we used the SE mouse model to specifically examine
the involvement of the subiculum and BLA in fear memory.
The correlation between c-Fos protein expression in the
hippocampus and the amygdala, and the behavioral changes,
determines if these regions play a role in contextual fear learning
and memory. We also examined the reorganization of the
BLA and the subiculum pathway in epilepsy, by morphological
analysis following the iontophoretical injection of an anterograde
tracer, PHA-L or a retrograde tracer, cholera toxin B subunit
(CTB) into the BLA.
MATERIALS AND METHODS
Pilocarpine Treatment
Handling and care of all animals were in compliance with the
NIH guidelines for animal research. All animal experiments were
approved by the Institutional Animal Care and Use Committee
at the Tan Tock Seng Hospital/National Neuroscience Institute.
Male Swiss mice (25–30 g) used for all experiments in
this study were treated as described previously (Ma et al.,
2006, 2008; Tang et al., 2006). In brief, mice were given a
single subcutaneous injection of methyl-scopolamine nitrate
(1 mg/kg) 30 min before the injection of either saline or
pilocarpine to limit the peripheral toxic effects. Mice in the
pilocarpine—injection group received pilocarpine (300 mg/kg)
through a single intraperitoneal injection. These mice exhibited
behavioral changes such as tremor, mild facial clonus, head
bobbing, hypoactivity and myoclonic movements of the limbs
for about 4 h. These symptoms eventually progressed to
recurrent myoclonic convulsions with falling, rearing and
SE. The mean latent period from pilocarpine treatment
to the first seizure observed is typically around 14 days.
Racine stages (Racine, 1972) were used for the scoring of
convulsive behavior, as follows: stage 0, no reaction; stage 1,
mouth and facial movements such as eye blinking, stereotypic
mouthing and/or mild facial clonus; stage 2, signs of severe
facial clonus and/or head nodding; stage 3, involuntary
myoclonic jerks in the forelimbs; stage 4, clonic convulsions
in the forelimbs with rearing; and stage 5, generalized motor
convulsions typically associated with the loss of balance. Mice at
2 months after pilocarpine-induced SE were designated as SE2m
groups.
Iontophoretical Injection of PHA-L or CTB
A total 50 mice were used (17 injected with saline and
33 injected with pilocarpine). Twenty-one of thirty-three
pilocarpine-injected mice survived (mortality rate: 36.36%) at
two months after injection (SE2m). These 17 saline-injected and
21 pilocarpine-injected mice were randomly allocated to four
experimental groups: (1) control with PHA-L (n = 8); (2) SE2m
with PHA-L (n = 11); (3) control with CTB (n = 9); and (4) SE2m
with CTB (n = 10). Four control mice (2 injected with PHA-L
and 2 injected with CTB) and 7 SE2m mice (four injected with
PHA-L and three injected with CTB) were excluded from data
analysis due to incorrect injection sites.
For injection of tracers, mice were first anesthetized with
chloral hydrate at a dose of 400 mg/kg. With the heads of the
mice immobilized using a Stoelting stereotaxic apparatus, small
holes were drilled through the skulls to form specific injection
sites positioned 1.6 mm posterior to bregma, 3.3 mm lateral to
midline and 4.2 mm ventral to the dura for the control mice
and 1.4 mm posterior to bregma, 3.1 mm lateral to midline and
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4.2 mm ventral to the dura for the epileptic mice. 10% CTB
(List Biological Laboratories, CA, USA) in distilled water or 2.5%
PHA-L (Vector Laboratories, Burlingame, CA, USA) in 0.1 M
phosphate buffered saline (pH 7.4) in a glass micropipette with
a diameter of 20–30 µm was delivered iontophoretically into the
BLA using a positive current of 5 µA (7 s on, 7 s off) over 10 min.
Animals were sacrificed at 7 days after CTB or PHA-L injection
and were perfused transcardially using 50 ml of saline, 100 ml of
4% paraformaldehyde and 0.15% picric acid in 0.1MPB at pH 7.4
for 30 min. Coronal brain sections of 40 µm thickness were cut
using a cryostat and the serial brain sections were collected in
individual wells of 24-well plates.
Immunocytochemical Studies
For immunohistochemistry, free-floating brain sections were
first washed with TBST (0.1 M Tris buffered saline (TBS)
containing 0.1% Triton-X 100). Brain sections were then
incubated overnight at 4◦C in mouse anti-NeuN antibody
(1:1000; Chemicon International, Inc., CA, USA), goat anti-c-Fos
antibody (1:1000; Santa Cruz Biotechnology, CA, USA), goat
anti-PHA-L antibody (1:5000; Vector Laboratories, Burlingame,
CA, USA), or goat anti-CTB antibody (1:2000; List Biological
Laboratories, CA, USA), then washed three times with TBST
before incubation in their respective secondary antibodies
diluted 1:500 with TBST (biotinylated-horse anti-goat IgG for
PHA-L or CTB; goat anti-mouse IgG for NeuN; or donkey anti-
goat IgG for Fos for 2 h at room temperature). Brain sections
were then incubated in avidin-biotin complex (ABC) reagent in
TBST for 2 h, washed with TBS and allowed to react in a solution
of 0.12% H2O2 and 0.05% DAB (Sigma-Aldrich, Missouri, USA)
in TBS for 20 min, mounted on glass slides, covered with
coverslips, and photographed using an image capture system.
PHA-L stained sections were also counterstained with cresyl fast
violet (CFV).
Double labeling of PHA-L with calbindin (CB), calretinin
(CR) or parvalbumin (PV) was carried out by incubating brain
sections in goat anti-PHA-L (1:1000), together with rabbit anti-
CB (1:2000), anti-CR (1:1500) or anti-PV (1:1500) for 48 h
at 4◦C. The brain sections were washed and incubated in
biotinylated horse anti-goat IgG (1:500) and swine anti-rabbit
IgG (1:100) for 4 h at room temperature, then incubated in
ABC solution for 2 h at room temperature before reaction
with 3,3′-diaminobenzidine (DAB)-Nickel solution for 20 min.
Subsequently, rabbit peroxidase anti-peroxidase (PAP; 1:100)
solution was added to the brain sections and left overnight to
incubate, and sections were then developed with DAB alone.
Cell Counting and Data Analysis
Every third sections were stained with antibodies against
NeuN or c-Fos for cell counting. BLA was determined
anteroposterior (AP) to Bregma (AP: −1.40 mm; −1.90 mm;
−2.30 mm). In the BLA, the total number of neurons per
area in the specified regions of interest (ROI) in control
mice and epileptic (SE2m) mice were quantified and the data
were normalized with area shrinkage of SE animals in the
specific brain regions. The c-Fos-expressing neurons in specific
brain regions such as the hippocampus (AP: −1.70 mm;
−1.94 mm; −2.18 mm), the dorsal (dSub) and ventral (vSub)
subiculum (AP: −3.28 mm; −3.40 mm; −3.52 mm), were also
counted and presented as density (number of immunopositive
neuron per square millimeter; No./mm2) normalized with cell
loss/area of SE animals as mean value ± standard deviation
(SD).
PHA-L-immunopositive terminal-like structures in the vSub
were visualized at high (400×) magnification (10× eyepiece
magnification plus 40× objective lens) using a Zeiss wide field
light microscope. These terminal-like structures were identified
based on their visibly enlarged structures seen on PHA-L-
immunopositive fibers. The numbers of these enlarged structures
on fibers per mm2 (No./mm2) at specific ROI were counted and
the data were normalized with area shrinkage of SE animals. ROI
is defined as the specific brain region of interest (e.g., v-Sub)
based on their anatomical locations in the brain. Images of the
ROI were taken at the focal planes of the ROI that showed
clearest and in-focused structures. The numbers of CB, CR or
PV-immunopositive neurons showing physical contacts with the
PHA-L-labeled terminal-like structures were also counted as
described above. In the vSub, CTB labeled neurons were counted
and presented as density (No./mm2) normalized with the area
in SE animals relative to the control animals. Imaging-Pro Plus
(Mediacybernetics, MD, USA) was used for all quantitative
analysis in this study. The neuronal profile counts were blinded.
Statistical analysis were done between the control and the SE2m
mice at different time points using one-way ANOVA followed
by Student-Newman-Keuls post hoc tests (for experiments with
more than two groups of data). For comparing experiments with
two groups of data, an independent samples test (t-test) was
used instead. A p-value of less than 0.05 is considered statistically
significant.
Contextual Fear Memory Test
Fear conditioning and retention memory tests were conducted
using a Y-maze with stainless-steel grid floor (30 × 10.5 ×
14.5 cm) as described previously (Vazdarjanova and McGaugh,
1999). The walls of the shock arm were decorated with red
wallpaper and two small red neon lights were installed on
the floor. The walls of the other two non-shock arms were
decorated with gold and silver wallpaper with two small green
neon lights installed on the floor. The floor of the shock arm
was connected to an AC shock generator controlled by a timer.
A video camera mounted 1.2 m above the maze was used to
monitor the behavioral changes of each mouse.
For behavioral experiments, a total of 42 mice were
used (12 for saline-injection and 30 for pilocarpine-injection).
Twenty out of the thirty pilocarpine-injected mice survived
(mortality rate: 33.33%) at 2 months after injection (SE2m).
Four experiment groups were designed for behavioral test
that included control/context group (N/C, n = 6), status
epilepticus/context (SE/C, n = 9) group, control/context with foot
shock group (N/CS, n = 6) and status epilepticus/context with
foot shock group (SE/CS, n = 11). Each mouse was handled for
1 min per day for 3 days before the start of training to reduce
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stress in the later training and test. The arms were thoroughly
cleaned with 10% ethanol solution directly after each training and
testing session. On Day 1 (habituation day), mice were allowed to
explore Y-maze freely for 8 min. The total numbers of entrance
to each arm were recorded. On Day 2 (training day), mice in
N/CS and SE/CS groups were placed in the shock arm that was
blocked off from the rest of the maze. After 120 s, mice in the
above two groups received four foot shocks each (0.3 mA AC,
1 s through stainless-steel grid delivered at 60 s intervals). Mice
were returned to the home cages 1 min after the last foot shock.
The total freezing times of each animal after each foot shock were
recorded. The freezing time for each session was presented as a
percentage of total observation. Mice in N/C and SE/C groups
were placed in the shock arm for the same period of time, without
receiving foot shocks. On Day 3 (test day), mice were placed
in a non-shock arm and allowed to access all arms of the maze
for 4 min. The total freezing time and latency to enter shock
or another non-shock arm were recorded. The percentage of the
number of the shock arm entries to all arm entries was calculated.
No shock was delivered on Day 3.
For statistical analysis of behavioral data, we used repeated-
measures-ANOVA to assess the effects of the lesion and foot
shock treatments on the freezing during training. The number of
entries, freezing time, first entry into the shock arm, foot shock
response and the time spent per arm of different experimental
groups were also compared using ANOVA. All post hoc
comparisons were done using Fisher’s tests. All probabilities less
than 0.05 are considered significant.
For immunohistochemistry studies, these animals were
sacrificed 1 h after the behavioral test.
RESULTS
Neuronal Loss in the BLA and vSub
of Epileptic Mice
The specific regions in BLA were determined and labeled
according to previous studies on the amygdaloidal complex
(Pitkänen et al., 1998; Sah et al., 2003). BLA comprises the
lateral (La), basal (B), and accessory basal (AB) nuclei. The lateral
nucleus is adjacent to the basal nucleus ventrally and is located
dorsally. This region is bordered medially by the central nucleus
(Ce) and laterally by the external capsule. The basal nucleus is
located ventral to the lateral nucleus and is subdivided into the
more caudal intermediate and parvocellular subdivisions, and the
rostral magnocellular subdivision. The AB nucleus lies adjacent
to the amygdalohippocampal area and is ventral to the basal
nucleus (Figures 1A,B).
Quantitative analysis showed that the areas of the La, B and
AB nuclei of the BLA are 0.1178 ± 0.0158, 0.2069 ± 0.0151 and
0.1420± 0.0115 mm2 in the epileptic mice (SE2m) and 0.1514±
0.0198, 0.2396 ± 0.032 and 0.1894 ± 0.0153 mm2 in the control
mice respectively. There were no significant differences in the La
and B nuclei areas (Student’s t-test, n.s. p > 0.05) between the
epileptic and control mice. However, a significant decreased in
the AB nucleus area (Student’s t-test, ∗p < 0.05) was observed in
the epileptic mice as compared to the control mice. Therefore, to
FIGURE 1 | Neuronal loss in the BLA and vSub of epileptic mice induced by pilocarpine treatment. Immunocytochemistry for NeuN shows the lateral (La),
basal (B) and accessory basal (AB) nuclei in BLA of control (A1–3) and epileptic mice (B1–3). Bar graph (C) shows the number of neurons (NeuN positive) per area
(mm2) in the different regions (La, B and AB) of the amygdala in epileptic mice (SE2m) normalized to the corresponding areas in control mice (Ctrl; Student’s t-test,
∗∗∗p < 0.001). Bar graphs (D–F) show the number of CB-, CR- or PV-immunopositive neurons (Student’s t-test, ∗∗∗p < 0.001) per area (mm2) at the La, B and AB
nuclei of amygdala in epileptic and control mice. Bar graph (G) shows the number of NeuN positive neurons per area (mm2) in the vSub of epileptic and control mice
(Student’s t-test, ∗∗∗p < 0.001). Bar graph (H) shows the number of CB-, CR- or PV-immunopositive neurons per area (mm2; Student’s t-test, ∗∗∗p < 0.001) at the
vSub in epileptic and control mice. Scale bar = 200 µm in (B3) applies to (A1–3) and (B1–2). The numbers of neurons per area in epileptic mice on all graphs were
normalized to the corresponding areas in control mice.
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account for this atrophy in the epileptic mice, total neurons per
area in the epileptic mice were normalized to the same area of the
control mice. NeuN immunocytochemistry showed 47.15, 43.26
and 56.80% reduction in total number of neurons at the La, B
and AB nuclei of the amygdala, respectively, in the epileptic mice
(SE2m) as compared to the control mice (Figures 1A–C). The
populations of CB-, CR- and PV-immunopositive neurons in
the epileptic mice were significantly decreased (Student’s t-test,
∗∗∗p < 0.001) at the La (48.24, 61.05, and 36.66% reduction), B
(26.56, 45.59, and 44.04% reduction) and AB (43.30, 52.27, and
36.79% reduction) nuclei of the amygdala (Figures 1D–F).
There was no significant area change (Student’s t-test,
p > 0.05) in the vSub of epileptic mice (0.7233 ± 0.0617 mm2)
as compared to control mice (0.6200 ± 0.0584 mm2). NeuN
immunocytochemistry showed a significant 28.06% reduction
in total number of neurons at the vSub in the epileptic mice
as compared to the control mice (Figure 1G). The numbers
of CB-, CR- and PV-immunopositive neurons were significant
decreased by 17.80, 39.98 and 28.80% respectively (Student’s
t-test, ∗∗∗p< 0.001) at the vSub in the epileptic mice (Figure 1H).
Pathological Changes of Afferent and
Efferent Pathways from the BLA in
Epileptic Mice
PHA-L was iontophoretically injected into the BLA in control
or epileptic mice and these mice were observed for PHA-L
labeling in the vSub (Figures 2A,B). Images taken at higher
magnification showed PHA-L-immunopositive fibers and
terminal-like structures (visible under high magnification
(Figures 2C1,D1) in the vSub of control and epileptic mice
(Figures 2C,D) indicating possible contact of neurons at BLA
with neurons at vSub. The density of terminal-like structures
on PHA-L-immunopositive fibers was also significantly higher
(25.63% increase) in the vSub of epileptic mice (average of
6019 terminal-like structures/mm2) compared to that of control
mice (average of 4476 terminal-like structures/mm2; Figure 2E;
Student’s t-test, ∗p< 0.05).
To determine the contact points of PHA-L-immunopositive
en passant and terminal-like structures in vSub, we
carried out double immunostaining of PHA-L with CB,
CR or PV. We found visible contacts between PHA-L
immunopositive en passant and terminal-like structures
and CB, CR or PV-immunopositive neurons in vSub of
mice in both the control (Figures 2F,H,J) and epilepsy
group (Figures 2G,I,K). Quantitative assessment showed
an increased number of CB, CR or PV immunopositive neurons
in the vSub contacted by PHA-L-labeled en passant and
terminal-like structures (Figure 2L) in the epileptic mice as
compared to the control mice (Student’s t-test, ∗∗∗p < 0.001,
∗∗p< 0.01).
Next, we iontophoretically injected CTB into the BLA
of control and epileptic mice to determine the retrograde
connections from BLA. CTB-immunopositive neurons were
found mainly in the ipsilateral vSub in both the control
(Figure 2M) and the epileptic mice (Figure 2N). However,
FIGURE 2 | Increased terminal-like structures in the vSub of epileptic mice. Representative images showing PHA-L-immunopositive fibers in the vSub region
of control (A,C) or epileptic (B,D) mice. Graph shows density of PHA-L-labeled terminal-like structures in both groups of mice normalized with area shrinkage in the
SE2m group (E) (Student’s t-test, ∗p < 0.05). Representative images showing double immunostaining of CB, CR or PV-positive cells with PHA-L-immunopositive
fibers in the control (F,H and J respectively) and epileptic (G,I and K respectively) mice. Graph shows quantification of the number of CB, CR or PV-immunopositive
neurons contacted by PHA-L labeled en passant and terminal-like structures in vSub normalized with CB, CR or PV-immunopositive neuronal loss in the SE2m
group (L) (Student’s t-test, ∗∗∗p < 0.001, ∗∗p < 0.01). Representative images showing CTB-immunopositive neurons at the ipsilateral vSub in control (M) and
epileptic (N) mice. Graph (O) showing the number of retrograde-labeled neurons per area in the ipsilateral vSub of control and epileptic mice normalized with
neuronal loss in the SE2m group (Student’s t-test, n.s. p > 0.05). Scale bar = 100 µm in (B) and (N) applies to (A,B) and (M,N). Scale bar = 50 µm in (D) applies to
(C,D). Scale bar = 10 µm in (K) applies to (F–J).
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quantitative assessment shows that the number of retrograde
labeled neurons in the ipsilateral vSub was not significantly
different in the epileptic mice as compared to the control mice
(Figure 2O; Student’s t-test, p> 0.05).
Impaired Learning and Memory Function in
Epileptic Mice
We next investigated if the structural changes in epileptic mice
were associated with functional consequences. Since epilepsy
has been shown to affect hippocampal functions, we selected
Y-maze contextual fear memory test to assess learning and
memory function in the control and epileptic mice. During
habituation (Day 1), mice in all groups explored all three arms
of the maze evenly and displayed no freezing. There were no
differences in the percentage of shock arm entries (Figure 3A,
Day 1) or shock arm stay (Figure 3B, Day 1) among the
groups of mice. On Day 2, when a series of four foot shocks
were given, the freezing time increased in both control and
epileptic mice (N/CS and SE/CS groups; Figure 3C). N/C
and SE/C group not subjected to foot shocks did not exhibit
any freezing response (Figure 3C). Further analysis with one-
way ANOVA followed by Newman-Keuls post hoc multiple
comparisons and a paired t-test indicated that the N/CS group
exhibited significantly longer freezing times after each of the
four foot shocks as compared to the SE/CS, SE/C and N/C
groups (ANOVA post hoc test, ∗∗∗p < 0.001; Figure 3C). There
was no significant difference in the percentage of freezing time
between SE/C and N/C groups (∗p > 0.05), but SE/CS group
showed significantly longer freezing times than N/C and SE/C
groups after each of the four shocks (ANOVA post hoc test,
∗∗∗p< 0.001).
On Day 3, all mice explored the shock arm, but the N/CS
group showed longer latency to enter the shock arm than
the SE/CS, N/C and SE/C groups (ANOVA post hoc test,
∗∗∗p < 0.001, Figure 3D). SE/CS group showed longer latency
to enter the shock arm compared to the N/C and SE/C groups
(ANOVA post hoc test, ∗∗∗p< 0.001, Figure 3D). The percentage
of shock arm entries to that of all arm entries was significantly
lower in the N/CS group than the N/C group (ANOVA post hoc
test, ∗∗p < 0.01) and the SE/CS group compared to the SE/C
group (ANOVA post hoc test, ∗p < 0.05; Figure 3A, Day 3).
The percentage of the shock arm stay to that of all arm stay was
significantly lower in the N/CS group compared to N/C group
(ANOVA post hoc test, ∗∗∗p< 0.001) and SE/CS group than SE/C
(ANOVA post hoc test, ∗∗p< 0.01; Figure 3B, Day 3).
Memory Test Enhances c-Fox Expression
in Epileptic Mice
c-Fos is required for hippocampal functions (Guzowski et al.,
2001). We found a significantly higher density of c-Fos-
immunopositive neurons in the N/CS group (Figures 4A–D),
specifically in the lateral (Figure 4E), basal (Figure 4F) and AB
FIGURE 3 | Pilocarpine-induced epilepsy in mice impairs fear memory. Graphs showing the percentage of shock arm entries (A) and shock arm stay (B) of
the four groups of mice (N/C—control mice, no foot shocks; N/CS—control mice, with foot shocks; SE/C—SE mice, no foot shocks; SE/CS—SE mice, with foot
shocks) on habituation day (day 1) and on test day (day 3). Graph showing the freezing time (sec) in control or SE mice with (N/CS and SE/CS groups) or without
(N/C and SE/C groups) foot shocks on day 2, when a series of four foot shocks was given (C). Graph shows the latency of first entry into the shock arm of the four
groups of mice as indicated (D) (ANOVA post hoc test, ∗∗∗p < 0.001, ∗∗p > 0.01, ∗p < 0.05).
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(Figure 4G) nuclei of the amygdala after the fear memory test
at Day 3 (ANOVA post hoc test, ∗∗∗p < 0.001) as compared to
the N/C, SE/C and SE/CS groups (Figures 4A–D). More c-Fos-
immunopositive neurons were observed in the basal nucleus
of SE/CS group than those in SE/C group (ANOVA post hoc
test, ∗∗∗p < 0.001; Figures 4A–D,F) indicating higher neuronal
activity in these neurons upon fear conditioning. However,
there are no significant changes in expression of c-Fos in
the lateral (Figure 4E) and AB (Figure 4G) nuclei of the
amygdala in SE/C and SE/CS groups (ANOVA post hoc test,
p> 0.05).
The density of c-Fos-immunopositive neurons in N/CS group
was increased significantly in the dorsal (dSub; Figures 5C,I)
and ventral (vSub; Figures 5D,J) subiculum (ANOVA post hoc
test, ∗∗∗p < 0.001) after the fear memory test at Day 3 (ANOVA
post hoc test, ∗∗∗p < 0.001) as compared to those in N/C
(Figures 5A,B,I,J), SE/C (Figures 5E,F,I,J) and SE/CS groups
(Figures 5G–J). However, more Fos-immunopositive neurons
in both areas (Figures 5E–J) were observed in SE/CS group
as compared to those in SE/C group (ANOVA post hoc test,
∗∗∗p< 0.001).
DISCUSSION
Pilocarpine-Induced SE Mouse to Study
Anatomical Changes in Different Brain
Regions in Epilepsy
Pilocarpine-induced SE, when not interrupted by drug
administration, is able to induce reorganization and anatomical
damage in brain regions such as the olfactory cortex, amygdala,
thalamus, hippocampus and neocortex (Curia et al., 2008;
Reddy and Kuruba, 2013). Pharmacological intervention,
such as diazepam, has been used to limit the SE duration to
reduce mortality as well as to confine neuronal damage to
the hippocampal formation and related limbic regions. One
study showed Fluorojade-positive neurodegeneration in near
30 brain regions with several of these regions well beyond
the temporal lobe in animals with 90 min of SE induced by
either systemic or intra-hippocampal pilocarpine aborted by
diazepam (Castro et al., 2011), However, the pilocarpine-induced
SE model used here without pharmacological intervention
is still widely used for studying pathological mechanisms
underlying epilepsy in general because animals with shorter
SE duration limited by drug treatment showed a higher
possibility of not developing spontaneous recurrent seizures
(SRSs).
Cytoarchitectonic Changes in the BLA of
Epileptic Mice
Neuronal loss and gliosis in the amygdala have been reported
in a large number of neuropathological studies using animal
TLE models and in patients with TLE (Turski et al., 1983;
Callahan et al., 1991; Wolf et al., 1997; Pitkänen et al.,
1998; Klitgaard et al., 2002; Bernasconi et al., 2003; Brandt
et al., 2006; Toyoda et al., 2013; Meletti et al., 2014).
However, there is still no detailed and thorough study on
the neuropathological changes in the amygdala of epileptic
mice. Herein, we observed substantial neuronal loss in the
BLA in these epileptic mice that exhibit deficits in contextual
fear memory. These data suggested that epilepsy affected
the structure of amygdala and the amygdala-dependent fear
memory. However, the BLA remained relatively undamaged
(∼66–76% of neurons), possibly providing residual connections
for fear-related behaviors.
FIGURE 4 | Increased expression of c-Fos at the BLA upon contextual learning and memory test. Representative images show c-Fos immunopositive
neurons in the amygdala of the four groups of mice after fear memory test at Day 3 (A–D). Graphs (E–G) showing the number of c-Fos-immunopositive cells per area
(mm2) in the lateral (E) basal (F) and accessory basal (G) nuclei of the amygdala after fear memory test at Day 3 in the four groups of mice normalized with neuronal
loss in the SE2m group (ANOVA post hoc test, ∗∗∗p < 0.001), Scale bar = 100 µm in (D) applies to (A–C). La, Lateral; B, Basal; C, Central; AB, Accessory Basal.
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FIGURE 5 | Increased expression of c-Fos at the vSub upon contextual learning and memory test. Representative images show c-Fos immunopositive
neurons in the dorsal (dSub) (A,C,E,G) and ventral (vSub) (B,D,F,H) subiculum in the different groups as indicated. Graphs (I,J) show quantification of
c-Fos-immunopositive neurons per area (mm2) in dSub (I) or vSub (J) normalized with neuronal loss in the SE2m group (ANOVA post hoc test, ∗∗∗p < 0.001). Scale
bar = 100 µm in (H) applies to (A–G).
Behavior Changes and c-Fos Activation in
Epilepsy
c-Fos is an immediate early gene. It is part of the activator
protein-1 transcription factor and has been postulated to
participate in the molecular mechanisms of learning and
memory. c-Fos was selected as a marker of neuronal activity
because it has been used to assess region-specific activity during
fear conditioning in previous studies (Campeau et al., 1991; Beck
and Fibiger, 1995; Rosen et al., 1998; Majak and Pitkänen, 2003;
Botterill et al., 2014). Our current observations and previous
studies showed a time-dependent increase in c-Fos protein in
the hippocampus, amygdala and other related regions. This
increased in expression occurred 30–90 min post training in
memory test, with expression peaking at 60min, and returning to
basal levels around 4 h (Dragunow and Faull, 1989; Tischmeyer
and Grimm, 1999). Therefore, immunohistochemical assays for
c-Fos expression were done 1 h after the behavioral test.
The shock-trained epileptic mice in our study entered the
shock arm with shorter latencies and at higher frequencies as
compared to the shock-trained control. This indicates that fear
memory of epileptic mice was significantly impaired. However,
we still observed increased c-Fos expression in the dentate gyrus
of epileptic mice. This increase in amygdala c-Fos expression
and that epileptic mice with significant neuronal loss in the
hippocampus could still demonstrate freezing responses upon
entering the shock arm suggest that another neural pathway is
involved in contextual fear memory. The relatively undamaged
BLA in the epileptic mice could potentially still play a role in fear
memory even when the hippocampus is substantially damaged.
Moreover, increased c-Fos expression, particularly in the BLA of
control mice upon contextual fear memory test provided further
evidence on the involvement of the BLA in foot shock dependent-
fear memory. These results are in agreement with previous
reports showing that cues-associated foot shock increases c-Fos
mRNA and protein expression in the amygdala (Campeau et al.,
1991; Beck and Fibiger, 1995; Rosen et al., 1998; Majak and
Pitkänen, 2003; Botterill et al., 2014).
Alteration of Neural Connections and
Learning and Memory in Epilepsy
Here, we report that epileptic mice have significantly higher
numbers of CR, CB or PV-immunopositive cells contacted by
PHA-L labeled en passant and terminal-like structures in the
v-Sub as compared to control mice. These connections are
important for synaptic excitability and plasticity in the efferent
and afferent pathways of BLA. The presence of ∼50% more
terminal-like structures in the v-Sub of epileptic mice that
were labeled with PHA-L injected at BLA may provide the
neuroanatomical basis to support the enhancement of interaction
between BLA and v-Sub in epilepsy. These findings suggest an
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enhanced or compensatory higher excitability of neurons in the
amygdala of epileptic mice.
Our data suggest that an increase in aberrant network
connections and compensatory mechanisms in the
parahippocampal formation may contribute to neurological
deficits in the epileptic mice and possibly, also in humans with
TLE. Therefore, a panoramic analysis beyond the temporal
lobe of these epileptic mice is essential for better understanding
the lesions and compensatory reorganization of circuitry in
epilepsy. Currently, reorganizations of the neural circuits in
several brain regions of this mouse epilepsy model including the
hippocampus (Ma et al., 2006; Zhang et al., 2009), the subiculum
(Tang et al., 2006; He et al., 2010) and the lateral entorhinal
cortex (Ma et al., 2008) have been reported. Following these
studies and our observations here on the amygdala, it will
be of interest to analyze the reorganizations of other neural
circuits directly connected with the hippocampus in epileptic
mice, such as the v-Sub-retrosplenial cortex (RSC) circuits,
perirhinal cortex (PRh)-hippocampus and PRh-entorhinal
cortex (EC)-hippocampus circuits as well as prefrontal cortex-
reuniens thalamic nucleus-hippocampus circuits.
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